What is the dosage and administration of metochlopramide (injection) for nausea and vomiting or gastroparesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoclopramide Injection Dosage for Nausea, Vomiting, and Gastroparesis

For gastroparesis and nausea/vomiting, metoclopramide injection should be administered at 10 mg intramuscularly or intravenously (given slowly over 1-2 minutes) every 6 hours, with intravenous administration preferred for severe symptoms. 1

Dosing Guidelines for Different Indications

Diabetic Gastroparesis

  • Initial treatment for severe symptoms:
    • 10 mg IV (administered slowly over 1-2 minutes) or IM every 6 hours
    • May require up to 10 days of parenteral therapy before transitioning to oral administration
    • Oral dosing: 5-20 mg three to four times daily 2

Nausea and Vomiting (General)

  • Standard dosing: 10 mg IM or IV every 6 hours

Chemotherapy-Induced Nausea and Vomiting

  • Administration: IV infusion over at least 15 minutes, 30 minutes before chemotherapy
  • Dosing schedule: Repeat every 2 hours for two doses, then every 3 hours for three doses
  • Dosage:
    • 2 mg/kg for highly emetogenic regimens (cisplatin, dacarbazine)
    • 1 mg/kg for less emetogenic regimens
    • For doses >10 mg, dilute in 50 mL normal saline 1

Postoperative Nausea and Vomiting

  • Timing: Near the end of surgery
  • Dosage: 10 mg IM (may use up to 20 mg) 1

Special Populations

Renal Impairment

  • For patients with creatinine clearance <40 mL/min, start with approximately half the recommended dose
  • Titrate based on efficacy and safety 1

Hepatic Impairment

  • No specific dose adjustment needed for patients with advanced liver disease if renal function is normal 1

Administration Considerations

IV Administration

  • Administer slowly over 1-2 minutes for direct IV push
  • For infusions, dilute in 50 mL of normal saline (preferred) or other compatible solutions
  • Diluted solutions can be stored:
    • Up to 4 weeks when frozen in normal saline
    • Up to 48 hours refrigerated (protected from light)
    • Up to 24 hours at room temperature under normal light conditions 1

Compatibility

  • Compatible with normal saline, Dextrose-5% in Water, Dextrose-5% in 0.45% Sodium Chloride, Ringer's Injection, and Lactated Ringer's Injection
  • Avoid freezing when mixed with Dextrose-5% in Water 1

Important Considerations

Duration of Treatment

  • FDA recommends limiting treatment duration due to risk of tardive dyskinesia
  • For gastroparesis, treatment beyond 12 weeks requires thorough risk-benefit assessment 3

Management of Acute Dystonic Reactions

  • If acute dystonic reactions occur, administer diphenhydramine 50 mg IM 1

Monitoring

  • Monitor for extrapyramidal symptoms, especially with prolonged use
  • Metoclopramide is the only FDA-approved medication for gastroparesis; all other agents are considered off-label 2

Remember that metoclopramide works by enhancing upper gastrointestinal motility and has both prokinetic and antiemetic properties, making it effective for both the delayed gastric emptying and the nausea/vomiting symptoms associated with gastroparesis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gastroparesis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.